Shelton Capital Management’s Globus Medical GMED Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2025
Q2 | $233K | Hold |
3,944
| – | – | 0.01% | 603 |
|
2025
Q1 | $289K | Hold |
3,944
| – | – | 0.01% | 485 |
|
2024
Q4 | $326K | Hold |
3,944
| – | – | 0.01% | 467 |
|
2024
Q3 | $282K | Hold |
3,944
| – | – | 0.01% | 532 |
|
2024
Q2 | $270K | Hold |
3,944
| – | – | 0.01% | 523 |
|
2024
Q1 | $212K | Hold |
3,944
| – | – | 0.01% | 686 |
|
2023
Q4 | $210K | Buy |
+3,944
| New | +$210K | 0.01% | 668 |
|
2023
Q3 | – | Sell |
-3,944
| Closed | -$235K | – | 710 |
|
2023
Q2 | $235K | Hold |
3,944
| – | – | 0.01% | 615 |
|
2023
Q1 | $223K | Hold |
3,944
| – | – | 0.01% | 621 |
|
2022
Q4 | $293K | Sell |
3,944
-263
| -6% | -$19.5K | 0.03% | 436 |
|
2022
Q3 | $251K | Hold |
4,207
| – | – | 0.01% | 524 |
|
2022
Q2 | $236K | Hold |
4,207
| – | – | 0.01% | 591 |
|
2022
Q1 | $310K | Hold |
4,207
| – | – | 0.01% | 518 |
|
2021
Q4 | $304K | Hold |
4,207
| – | – | 0.01% | 548 |
|
2021
Q3 | $322K | Hold |
4,207
| – | – | 0.01% | 522 |
|
2021
Q2 | $326K | Hold |
4,207
| – | – | 0.01% | 531 |
|
2021
Q1 | $259K | Hold |
4,207
| – | – | 0.01% | 623 |
|
2020
Q4 | $274K | Sell |
4,207
-278
| -6% | -$18.1K | 0.01% | 526 |
|
2020
Q3 | $222K | Hold |
4,485
| – | – | 0.01% | 643 |
|
2020
Q2 | $214K | Buy |
+4,485
| New | +$214K | 0.01% | 566 |
|
2020
Q1 | – | Sell |
-5,100
| Closed | -$300K | – | 718 |
|
2019
Q4 | $300K | Hold |
5,100
| – | – | 0.02% | 520 |
|
2019
Q3 | $261K | Sell |
5,100
-332
| -6% | -$17K | 0.02% | 594 |
|
2019
Q2 | $230K | Buy |
5,432
+5,164
| +1,927% | +$219K | 0.01% | 695 |
|
2019
Q1 | $5.43K | Sell |
268
-5,164
| -95% | -$105K | 0.02% | 555 |
|
2018
Q4 | $235K | Hold |
5,432
| – | – | 0.02% | 603 |
|
2018
Q3 | $308K | Hold |
5,432
| – | – | 0.02% | 571 |
|
2018
Q2 | $274K | Hold |
5,432
| – | – | 0.02% | 619 |
|
2018
Q1 | $271K | Hold |
5,432
| – | – | 0.02% | 606 |
|
2017
Q4 | $223K | Buy |
+5,432
| New | +$223K | 0.01% | 756 |
|